The Avdoralimab Biosimilar Anti-C5aR1 Antibody is a groundbreaking product designed for research involving the C5a receptor 1 (C5aR1), an important mediator of inflammation and immune response. This biosimilar antibody, developed using advanced technology, offers high sensitivity and specificity for detecting and studying C5aR1 in various biological samples.C5aR1 is a key component of the complement system, playing a critical role in inflammation, tissue damage, and immune cell activation. By targeting C5aR1, researchers can gain valuable insights into the mechanisms underlying immune-mediated diseases such as sepsis, autoimmune disorders, and inflammatory conditions like arthritis.
With its superior performance in applications such as immunohistochemistry, flow cytometry, and ELISA, the Avdoralimab Biosimilar Anti-C5aR1 Antibody is a versatile tool for investigating the role of C5aR1 in health and disease. Its reliable results and consistent performance make it an essential reagent for studies in immunology, inflammation, and drug development.
Product Name:
Avdoralimab (Anti-C5AR1) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0099
Target:
C5AR1
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
IPH-5401, NN-8210, NNC-0215-0384
Description:
Anti-C5AR1(avdoralimab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.